Shennon Biotechnologies, a San Francisco, CA-based biotechnology company developing precision immunotherapies for cancer, raised $12M in funding . Backers included Future Ventures, NextGen Venture Partners, Samos Investments, Atypical Ventures, Saras Capital, DCVC, Foundation Capital, and AV8 Ventures....See more